Sequencing continues to have the potential to remodel medical microbiology and even public well being by enabling the simultaneous, hypothesis-free identification of a number of disease-causing organisms (together with micro organism, viruses, fungi and parasites). A number of approaches for such a testing exist – from sampling of microbes in sources of an infection to newer cell-free approaches from physique fluids. Regardless of its super promise, sequencing has not seen the routine uptake many predicted as a consequence of a wide range of technical, scientific and broader structural causes.
Whereas implementation in routine apply stays in early levels, the potential influence on healthcare supply and affected person outcomes warrants critical consideration from forward-looking healthcare leaders.
Be a part of us for a dynamic moderated dialogue between two well known specialists within the discipline of microbiology, Charles Chiu, MD PhD, and Brad Perkins, MD, as they focus on the way forward for sequencing in medical microbiology.
Dialogue Highlights:
- Sequencing’s transformative potential in diagnostics.
- Actual-world affected person influence and success tales.
- Assessing the place we’re within the adoption cycle.
- Advances in numerous sorts of methodologies, infrastructure, and approaches.
- Addressing unmet wants in infectious illness diagnostics and healthcare supply.
- Constructing the medical proof base to drive broader adoption.
- Overcoming boundaries by innovation, collaboration, and guideline improvement.
- Envisioning the long run.
